Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/126172Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gascón-Bayarri, Jordi | - |
| dc.contributor.author | Campdelacreu i Fumadó, Jaume | - |
| dc.contributor.author | Estela, Jordi | - |
| dc.contributor.author | Reñé Ramírez, Ramon | - |
| dc.date.accessioned | 2018-11-16T09:49:15Z | - |
| dc.date.available | 2018-11-16T09:49:15Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.uri | https://hdl.handle.net/2445/126172 | - |
| dc.description.abstract | Ornithine transcarbamylase deficiency (OTCD) is a rare X-linked disorder of urea synthesis leading to hyperammonemia. Several late-onset cases have been reported. Undiagnosed and untreated patients are at the risk of death or suffering from irreversible sequelae. We describe a 56-year-old patient who presented with acute encephalopathy after steroid treatment. Hyperammonemia due to OTCD was diagnosed and a mutation was found. This allowed us to diagnose two other family members with unexplained encephalopathy who are now asymptomatic on a low-protein diet. OTCD should be considered in any patient with hyperammonemic encephalopathy and immediate treatment should be given to avoid a fatal outcome. We emphasize the need to examine other family members if the diagnosis is confirmed, in order to prevent further life-threatening episodes of encephalopathy or neonatal coma of newborn. | - |
| dc.format.extent | 3 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | Hindawi Ltd | - |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1155/2015/453752 | - |
| dc.relation.ispartof | Case Reports in Neurological Medicine, 2015, vol. | - |
| dc.relation.uri | https://doi.org/10.1155/2015/453752 | - |
| dc.rights | cc by (c) Gascón Bayarri et al., 2015 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
| dc.subject.classification | Malalties rares | - |
| dc.subject.classification | Malalties cerebrals | - |
| dc.subject.other | Rare diseases | - |
| dc.subject.other | Brain diseases | - |
| dc.title | Severe Hyperammonemia In Late-onset Ornithine Transcarbamylase Deficiency Triggered By Steroid Administration | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.date.updated | 2018-07-24T12:35:22Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| dc.identifier.pmid | 25949836 | - |
| Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Gascon-BayarriJ.pdf | 1.22 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
